Neuronetics Inc
STIM
Detailliertes Diagramm anzeigen
2.520USD
-0.220-8.03%
Handelsschluss 11/06, 16:00（ET）Kurse um 15 Minuten verzögert
172.48MMarktkapitalisierung
VerlustKGV TTM
Intraday
1m
30m
1h
D
W
M
D
Heute
-8.03%
5 Tage
-6.67%
1 Monat
-10.95%
6 Monate
-44.00%
Seit Jahresbeginn
+56.52%
1 Jahr
+111.76%
Detailliertes Diagramm anzeigen
TradingKey Aktienbewertung von Neuronetics Inc
Währung: USD Aktualisiert: 2025-11-06Wichtige Einblicke
Die Fundamentaldaten des Unternehmens sind relativ stabil. Seine Bewertung wird als angemessen bewertet angesehen,und die institutionelle Anerkennung ist sehr hoch. In den letzten 30 Tagen haben mehrere Analysten die Aktie mit einer Kaufen bewertet. Trotz einer schwachen Aktienmarktperformance zeigt das Unternehmen starke Fundamentaldaten und technische Indikatoren. Der Aktienkurs bewegt sich seitwärts zwischen den Unterstützungs- und Widerstandsniveaus, was ihn für schwankungsorientiertes Trading geeignet macht.
Neuronetics Inc Bewertung
Widerstand & Unterstützung
Keine Daten
Radar Chart
Aktueller Preis
Vorher
Analysten-Ziel
Basierend auf insgesamt
3
Analysten
Kaufen
Aktuelles Rating
6.500
Kursziel
+137.23%
Aufwärtspotenzial
Hinweis: Analystenbewertungen und Kursziele werden von LSEG ausschließlich zu Informationszwecken bereitgestellt und stellen keine Anlageberatung dar.
Neuronetics Inc Highlights
HöhepunkteRisiko
Neuronetics, Inc. is a medical technology company focused on designing, developing, and marketing products for patients who suffer from neurohealth disorders. Its NeuroStar Advanced Therapy for Mental Health is a non-drug, noninvasive treatment for people suffering from neurohealth conditions. In addition to selling the NeuroStar system and associated treatment sessions to customers, it operates treatment centers across the United States, offering both NeuroStar Advanced Therapy (transcranial magnetic stimulation or TMS) and Spravato (esketamine nasal spray) for the treatment of major depressive disorder (MDD) and other mental health disorders. NeuroStar Advanced Therapy is the TMS treatment for MDD in adults. Spravato is offered to treat adults with treatment-resistant depression and depressive symptoms in adults with MDD with suicidal thoughts or actions. It provides more than 1.68 million treatments to over 51,000 patients struggling with depression.
performance_growth_period
performance_growth_period_desc%!(EXTRA string=74.89M)
high_profit_growth
high_profit_growth_desc%!(EXTRA string=74.89M)
valuation_underestimated
valuation_underestimated_desc%!(EXTRA string=PE, string=-3.03)
institutional_decreasing_position
institutional_decreasing_position_desc%!(EXTRA string=39.02M, string=26.04%)
institutional_hold%!(EXTRA string=The Vanguard)
institutional_hold_desc%!(EXTRA string=The Vanguard, string=2.74M)
activity_increase
activity_increase_desc%!(EXTRA string=0.95)
Neuronetics Inc Nachrichten
Bald gibt es mehr Neuigkeiten, bleiben Sie dran...
Finanzindikatoren
EPS
Keine Daten
Gesamteinnahmen
Keine Daten
Neuronetics Inc Informationen
Neuronetics, Inc. is a medical technology company focused on designing, developing, and marketing products for patients who suffer from neurohealth disorders. Its NeuroStar Advanced Therapy for Mental Health is a non-drug, noninvasive treatment for people suffering from neurohealth conditions. In addition to selling the NeuroStar system and associated treatment sessions to customers, it operates treatment centers across the United States, offering both NeuroStar Advanced Therapy (transcranial magnetic stimulation or TMS) and Spravato (esketamine nasal spray) for the treatment of major depressive disorder (MDD) and other mental health disorders. NeuroStar Advanced Therapy is the TMS treatment for MDD in adults. Spravato is offered to treat adults with treatment-resistant depression and depressive symptoms in adults with MDD with suicidal thoughts or actions. It provides more than 1.68 million treatments to over 51,000 patients struggling with depression.
BörsenkürzelSTIM
UnternehmenNeuronetics Inc
CEOMr. Keith J. Sullivan
Websitehttps://neurostar.com/neuronetics/
Verwandte Finanzinstrumente
-1.89%
+0.33%
-0.29%
-0.14%
-0.73%
+0.15%
-1.08%
-0.38%
-0.39%
+0.14%
+1.76%
-1.14%
-1.23%
-0.90%
+0.57%
-0.48%
-1.37%
+0.49%
-0.09%
+1.81%Beliebte Symbole
